25 May 2013
Keywords: imclone, net, loss, falls, revenues, rise, biopharmaceutical
Article | 22 March 2004
US biopharmaceutical company, ImClone Systems, recently at the center of the Martha Stewart insider-trading litigation, has reported a
narrower loss ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 March 2004
15 March 2004
24 May 2013
© 2013 thepharmaletter.com